BellaSeno Appoints Dr. Thomas Lingner as Chief Technology Officer and Inga Freyert as VP Quality and Regulatory Affairs
Leipzig, Germany, April 3, 2024 – BellaSeno GmbH , an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, announced today that Dr. Thomas Lingner was appointed Chief Technology Officer and Inga Freyert was promoted to VP Quality and Regulatory Affairs.
- Leipzig, Germany, April 3, 2024 – BellaSeno GmbH , an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, announced today that Dr. Thomas Lingner was appointed Chief Technology Officer and Inga Freyert was promoted to VP Quality and Regulatory Affairs.
- Inga Freyert served as BellaSeno´s Head of Quality Management since 2022 and was promoted to VP Quality Management and Regulatory Affairs in early 2024.
- Before joining bess pro GmbH, Inga Freyert worked as Quality & Regulatory Specialist / Junior Q&R Manager at MagForce AG, Berlin.
- “We warmly welcome Dr. Thomas Lingner and Inga Freyert to their new roles at BellaSeno,” said Dr. Mohit Chhaya, CEO of BellaSeno.